Anxiety in health personnel of the Hospital of the Ministry of Health during the COVID-19 pandemic in the Southern Region of Peru

Authors

  • Agueda Muñoz-del-Carpio-Toia Universidad Católica de Santa María, Arequipa, Perú https://orcid.org/0000-0003-0501-7314
  • Yury Merma Barazorda Universidad Católica de Santa María, Arequipa, Perú https://orcid.org/0000-0002-2363-1273
  • Walter L. Arias Gallegos Universidad Católica San Pablo, Arequipa, Perú
  • Lucía Begazo-Muñoz-del-Carpio Universidad Católica de Santa María, Arequipa, Perú
  • Francesca Diaz Del Olmo Calvo William Peace University, Carolina del Norte, Estados Unidos
  • Renzo Rivera Universidad Católica San Pablo, Arequipa, Perú https://orcid.org/0000-0002-5897-9931
  • Patricio Diaz Del Olmo Calvo Emory & Henry University, Virginia, Estados Unidos https://orcid.org/0009-0005-5904-2269
  • Paulina Patricia Valdivia Carazas Universidad Católica de Santa María, Arequipa, Perú
  • Magly Liesbeth Larico Centro de Salud Mental Comunitario Hunter, Arequipa, Perú
  • Tomás Caycho-Rodríguez Universidad Científica del Sur, Lima, Perú https://orcid.org/0000-0002-5349-7570

DOI:

https://doi.org/10.52379/mcs.v9.554

Keywords:

Anxiety, COVID-19, healthcare workers, pandemic

Abstract

Introduction: The pandemic of COVID-19 had affected dramatically the mental health of general population, but specifically the health personnel, so there were reported higher levels of anxiety in physicians and nurses in several countries. Objective: To determine the levels of anxiety in health personnel who work in Hospital from Ministry of Health Hospital from Arequipa City and its association with the attemption of patients with COVID-19. Methodology: This is a descriptive transectional study, in which there were assessed 147 healthcare workers in Hospital with and there Zung Axiety Scale. Results: The 53.1% of the health personnel assessed presents some levels of anxiety, that is associated in the 66% of the cases with ethical dilemmas for working with people infected with COVID-19. Conclusion: There is a significant association between anxiety and the attemption of patients with COVID-19.

Downloads

Download data is not yet available.

References

1. Gómez-Bañuelos E, Fava A, Andrade F. An update on autoantibodies in systemic lupus erythematosus. Curr Opin Rheumatol. 2023;35(2):61-67. https://doi.org/10.1097/BOR.0000000000000922

2. Kiriakidou M, Ching CL. Systemic Lupus Erythematosus. Ann Intern Med. 2020;172(11):ITC81-ITC96. https://doi.org/10.7326/AITC202006020

3. Yu H, Nagafuchi Y, Fujio K. Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus. Biomolecules. 2021;11(7):928. https://doi.org/10.3390/biom11070928

4. Zucchi D, Silvagni E, Elefante E, et al. Systemic lupus erythematosus: one year in review 2023. Clin Exp Rheumatol. 2023;41(5):997-1008. https://doi.org/10.55563/clinexprheumatol/4uc7e8

5. Arnaud L, Chasset F, Martin T. Immunopathogenesis of systemic lupus erythematosus: An update. Autoimmun Rev. 2024;23(10):103648. https://doi.org/10.1016/j.autrev.2024.103648

6. Accapezzato D, Caccavale R, Paroli MP, et al. Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. Int J Mol Sci. 2023;24(7):6578. https://doi.org/10.3390/ijms24076578

7. Yu C, Li P, Dang X, Zhang X, Mao Y, Chen X. Lupus nephritis: new progress in diagnosis and treatment. J Autoimmun. 2022;132:102871. https://doi.org/10.1016/j.jaut.2022.102871

8. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(9):1400-1412. https://doi.org/10.1002/art.40930

9. Reátegui-Sokolova C, Ugarte-Gil MF, Harvey GB, et al. Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL). RMD Open. 2020;6(3):e001299. https://doi.org/10.1136/rmdopen-2020-001299

10. Fanouriakis A, Kostopoulou M, Andersen J, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83(1):15-29. https://doi.org/10.1136/ard-2023-224762

11. Ahn SS, Jung SM, Yoo J, Lee SW, Song JJ, Park YB. Anti-Smith antibody is associated with disease activity in patients with new-onset systemic lupus erythematosus. Rheumatol Int. 2019;39(11):1937-1944. https://doi.org/10.1007/s00296-019-04445-y

12. Dima A, Jurcut C, Baicus C. The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease. Rheumatol Int. 2018;38(7):1169-1178. https://doi.org/10.1007/s00296-018-4059-4

13. Pisetsky DS. Evolving story of autoantibodies in systemic lupus erythematosus. J Autoimmun. 2020;110:102356. https://doi.org/10.1016/j.jaut.2019.102356

14. Meroni PL, Tsokos GC. Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Front Immunol. 2019;10:199. https://doi.org/10.3389/fimmu.2019.00199

15. Crow MK. Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets. Ann Rheum Dis. 2023;82(8):999-1014. https://doi.org/10.1136/ard-2022-223741

16. Siegel CH, Sammaritano LR. Systemic Lupus Erythematosus: A Review. 2024;331(24):2136]. JAMA. 2024;331(17):1480-1491. https://doi.org/10.1001/jama.2024.2315

17. Lou H, Ling GS, Cao X. Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target. J Autoimmun. 2022;132:102861. https://doi.org/10.1016/j.jaut.2022.102861

18. Alforaih N, Whittall-Garcia L, Touma Z. A Review of Lupus Nephritis. J Appl Lab Med. 2022;7(6):1450-1467. https://doi.org/10.1093/jalm/jfac036

19. Lai NS, Lu MC, Chang HH, Lo HC, Hsu CW, et al. Comparison of the Correlation of Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) with Health-Related Quality of Life. J Clin Med. 2021;10(10):2137. https://doi.org/10.3390/jcm10102137

20. Walace D. Clinical manifestations and diagnosis of systemic lupus erythematosus in adults. UpToDate. 2023.

21. Renée SD, Mercado U. Características clínicas e inmunológicas de lupus eritematoso sistémico aplicando los criterios de clasificación de EULAR/ACR 2019. Med Int Mex. 2022;38(3):507-513. https://doi.org/10.24245/mim.v38i3.5146

22. Maloney KC, Ferguson TS, Stewart HD, Myers AA, De Ceulaer K. Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: a comparative analysis. Lupus. 2017;26(13):1448-1456. https://doi.org/10.1177/0961203317707828

23. Moriano C, Bellido-Pastrana D, San Román Gutiérrez C, Rodríguez E. Evolution of diagnosis and treatment for lupus nephritis in Spain. Nefrologia (Engl Ed). 2023;43(6):668-675. https://doi.org/10.1016/j.nefroe.2023.12.006

24. Heimovski FE, Simioni JA, Skare TL. Systemic lupus erythematosus and Raynaud's phenomenon. An Bras Dermatol. 2015;90(6):837-840. https://doi.org/10.1590/abd1806-4841.20153881

Downloads

Published

09/03/2025

Issue

Section

Original Articles

Similar Articles

1-10 of 248

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 > >>